TuHURA Biosciences Stock (NASDAQ:HURA)

Ownership Financials Chart

Previous Close

$2.37

52W Range

$1.80 - $8.40

50D Avg

$2.67

200D Avg

$3.49

Market Cap

$129.62M

Avg Vol (3M)

$500.49K

Beta

-0.10

Div Yield

-

HURA Company Profile

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19

IPO Date

Feb 22, 2013

Website

HURA Performance

HURA Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-29.76M	$-9.93M	$-7.25M
Net Income	$-29.32M	$-9.37M	$-7.02M
EBITDA	$-29.12M	$-9.56M	$-6.01M
Basic EPS	$-0.12	$-202.39	$-0.17
Diluted EPS	$-0.12	$-202.39	$-0.17

Fiscal year ends in Dec 23 | Currency in USD